Literature DB >> 27160408

Somatic Mutation Theory - Why it's Wrong for Most Cancers.

Björn L D M Brücher, Ijaz S Jamall.   

Abstract

Hysteron proteron reverses both temporal and logical order and this syllogism occurs in carcinogenesis and the somatic mutation theory (SMT): the first (somatic mutation) occurs only after the second (onset of cancer) and, therefore, observed somatic mutations in most cancers appear well after the early cues of carcinogenesis are in place. It is no accident that mutations are increasingly being questioned as the causal event in the origin of the vast majority of cancers as clinical data show little support for this theory when compared against the metrics of patient outcomes. Ever since the discovery of the double helical structure of DNA, virtually all chronic diseases came to be viewed as causally linked to one degree or another to mutations, even though we now know that genes are not simply blueprints, but rather an assemblage of alphabets that can, under non-genetic influences, be used to assemble a business letter or a work of Shakespearean literature. A minority of all cancers is indeed caused by mutations but the SMT has been applied to all cancers, and even to chemical carcinogenesis, in the absence of hard evidence of causality. Herein, we review the 100 year story of SMT and aspects that show why genes are not just blueprints, how radiation and mutation are associated in a more nuanced view, the proposed risk of cancer and bad luck, and the in vitro and in vivo evidence for a new cancer paradigm. This paradigm is scientifically applicable for the majority of non-heritable cancers and consists of a six-step sequence for the origin of cancer. This new cancer paradigm proclaims that somatic mutations are epiphenomena or later events occurring after carcinogenesis is already underway. This serves not just as a plausible alternative to SMT and explains the origin of the majority of cancers, but also provides opportunities for early interventions and prevention of the onset of cancer as a disease.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27160408     DOI: 10.1159/000443106

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  18 in total

Review 1.  Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.

Authors:  Robert A Gatenby; Joel Brown
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-21       Impact factor: 10.680

Review 2.  Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches.

Authors:  Ion G Motofei
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

Review 3.  The impact of fusion genes on cancer stem cells and drug resistance.

Authors:  Saurav Panicker; Sivaramakrishnan Venkatabalasubramanian; Surajit Pathak; Satish Ramalingam
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

4.  Cancer Prevention and Treatment by Wholistic Nutrition.

Authors:  T Colin Campbell
Journal:  J Nat Sci       Date:  2017-10

Review 5.  Bioinformatics and Drug Discovery.

Authors:  Xuhua Xia
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

Review 6.  DNA Damage, Mutagenesis and Cancer.

Authors:  Ashis K Basu
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

7.  An Emergence Framework of Carcinogenesis.

Authors:  Elizabeth A W Sigston; Bryan R G Williams
Journal:  Front Oncol       Date:  2017-09-14       Impact factor: 6.244

Review 8.  Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation.

Authors:  Said M Afify; Masaharu Seno
Journal:  Cancers (Basel)       Date:  2019-03-11       Impact factor: 6.639

Review 9.  A Review of Last Decade Developments on Epiretinal Membrane Pathogenesis.

Authors:  Eleni Tsotridou; Eleftherios Loukovitis; Konstantinos Zapsalis; Iro Pentara; Solon Asteriadis; Paris Tranos; Zachos Zachariadis; George Anogeianakis
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2020-03-20

Review 10.  From cancer to rejuvenation: incomplete regeneration as the missing link (part II: rejuvenation circle).

Authors:  Mamuka G Baramiya; Eugene Baranov; Irina Saburina; Lev Salnikov
Journal:  Future Sci OA       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.